Observational Study With PASCALLERG ® in Patients With Hay Fever

NCT01660737•Pascoe Pharmazeutische Praeparate GmbH

Summary

The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.

Detailed Description

There are documented male and female patients over the age of one year who suffer from hay fever. The traetment time is about a period of 4 weeks with PASCALLERG® tablets.

Eligibility

Age

1 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•hay fever

Exclusion Criteria

•Lactose intolerance and / or
•Chromium hypersensitivity

Locations (1)

Jennifer Lebert

Giessen, Germany

Key Dates

Start Date

February 1, 2012

Primary Completion Date

July 1, 2013

Completion Date

July 1, 2013

Last Updated

March 30, 2021

Enrollment

123

ACTUAL participants

Conditions

Hay Fever

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

NCT04622917

Rhinitis, Allergic, SeasonalHay Fever+2 more

View study

COMPLETEDPHASE2

PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)

NCT00574210

Seasonal Allergic RhinitisHay Fever+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 30, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Observational Study With PASCALLERG ® in Patients With Hay Fever

Inclusion Criteria

Exclusion Criteria

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)

Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)

Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis